Beijing Infoark Technology Development Co., Ltd

Country/Region: China     State/Province: Beijing

Main Products: Intermediates Of Montelukast Sodium, Sratrodast, Repaglinide, Rasagiline Mesylate, Rosuvastatin, Gemcitabine Hydrochloride, Sitagliptin Phosphate, Cinacalcet, Sorafinib, Tosylate, Atovaquone, Pregabalin.....chrial Compounds, Intermediates Of Montelukast Sodium

Company Introduction
Beijing Infoark Technology Development Co., Ltd is grounded on a mission to be the world’s leading edge Cinacalcet Manufacturer and Exporter. Our product line revolves around Intermediates of Montelukast sodium,Sratrodast,Repaglinide,Rasagiline Mesylate,Rosuvastatin,Gemcitabine hydrochloride,Sitagliptin phosphate,Cinacalcet,Sorafinib ,Tosylate,Atovaquone,Pregabalin.....chrial compounds being manufactured in Beijing, Beijing, China. We have established our benchmark as one of the best Private Owner company delivering high end Cinacalcet since 2004.We understand the global demand to access the reviving Cinacalcet and to cope with it our strong workforce leverages on a well developed manufacturing unit boasting 16 Years of export history with generating yearly revenue around Approx More Than 1 Billion US Dollar. Our professional enterprise was introduced with initial business capital of US$10 Million - US$50 Million, houses first in class technicians and a strong quality management system that helped us capture US$2.5 Million - US$5 Million worth export value and Australia,Canada,Indonesia,India,United Kingdom market share.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2004, 2004

Legal Status: Agency

Ownership: Private Owner

Employees: 201 - 300 People

Factory Size: 5, 000-10, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: SA8000

Contact Information

Contact Person: Yanjie Sun

Designation: Director

Department: Owner/Sales consultant

Telephone: 086-15911168759

Business Information

Main Markets: Canada (27%) United Kingdom (22%) Indonesia (18%) Australia (16%) India (11%)

Export Focus: Australia, Canada, Indonesia, India, United Kingdom

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 41% - 50%

Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Credit Card (CC), PayPal

Product Showcase
Intermediates of Montelukast sodium
Sratrodast
Repaglinide
Rasagiline Mesylate
Rosuvastatin
Gemcitabine hydrochloride
Sitagliptin phosphate
Cinacalcet
Sorafinib
Tosylate
Atovaquone
Pregabalin.....chrial compounds
Intermediates of Montelukast sodium

CL-Link > Health & Medicines in China Health & Medicines in Beijing Medicines in China Medicines in Beijing